CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 257 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01821300
NCT01821300N/ACompleted
CompareCT.gov

Cardiometabolic Risk and Obesity in Adolescents With Down Syndrome

Children's Hospital of Philadelphia·observational·Posted Apr 1, 2013·Updated Jul 31, 2019

In Brief

An observational study for Down Syndrome and Trisomy 21. Completed, enrolled 257 participants across 2 sites.

Detailed Summary

The purpose of this research study is to determine which measures best capture cardiovascular disease (CVD) risk and type 2 diabetes (T2DM) risk in children and adolescents with Down syndrome (DS). We hypothesize that DS is associated with worse cardiometabolic risk factors for a given body mass index compared to controls. This difference arises at least in part, from increased fat tissue.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDown Syndrome, Trisomy 21
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedApr 1, 2013
Enrollment StartFeb 1, 2013
Primary CompletionAug 25, 2017
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 13.3 years ago